Evidence map›Paper›PMID 39264364›Full record

ArticleeLife2024

Altered firing output of VIP interneurons and early dysfunctions in CA1 hippocampal circuits in the 3xTg mouse model of Alzheimer's disease.

Felix Michaud, Ruggiero Francavilla, Dimitry Topolnik, Parisa Iloun, Suhel Tamboli, Frederic Calon, Lisa Topolnik

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Felix Michaud *Department of Biochemistry, Microbiology and Bio-informatics, Laval University, Québec, Canada.
Ruggiero Francavilla *Department of Biochemistry, Microbiology and Bio-informatics, Laval University, Québec, Canada.
Dimitry TopolnikDepartment of Biochemistry, Microbiology and Bio-informatics, Laval University, Québec, Canada.
Parisa IlounDepartment of Biochemistry, Microbiology and Bio-informatics, Laval University, Québec, Canada.
Suhel TamboliDepartment of Biochemistry, Microbiology and Bio-informatics, Laval University, Québec, Canada.
Frederic CalonNeuroscience Axis, CHU de Québec Research Center (CHUL), Québec, Canada.
Lisa TopolnikDepartment of Biochemistry, Microbiology and Bio-informatics, Laval University, Québec, Canada.ORCID https://orcid.org/0000-0003-4236-5473

Funding

CIHR MOP-137072CIHR MOP-142447Natural Sciences and Engineering Research Council of Canada 342292
6 · The paper itself

Abstract

Alzheimer's disease (AD) leads to progressive memory decline, and alterations in hippocampal function are among the earliest pathological features observed in human and animal studies. GABAergic interneurons (INs) within the hippocampus coordinate network activity, among which type 3 interneuron-specific (I-S3) cells expressing vasoactive intestinal polypeptide and calretinin play a crucial role. These cells provide primarily disinhibition to principal excitatory cells (PCs) in the hippocampal CA1 region, regulating incoming inputs and memory formation. However, it remains unclear whether AD pathology induces changes in the activity of I-S3 cells, impacting the hippocampal network motifs. Here, using young adult 3xTg-AD mice, we found that while the density and morphology of I-S3 cells remain unaffected, there were significant changes in their firing output. Specifically, I-S3 cells displayed elongated action potentials and decreased firing rates, which was associated with a reduced inhibition of CA1 INs and their higher recruitment during spatial decision-making and object exploration tasks. Furthermore, the activation of CA1 PCs was also impacted, signifying early disruptions in CA1 network functionality. These findings suggest that altered firing patterns of I-S3 cells might initiate early-stage dysfunction in hippocampal CA1 circuits, potentially influencing the progression of AD pathology.

Indexed as

Alzheimer DiseaseCA1 Region, HippocampalInterneuronsVasoactive Intestinal PeptideAction PotentialsAnimalsDisease Models, AnimalHumansMaleMiceMice, TransgenicVasoactive Intestinal PeptideAlzheimer's diseasecircuitdisinhibitionhippocampusinhibitionmemorymouseneuroscience

Identifiers

PMID39264364
PMCPMC11392531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.